1. Barandun, S. (1985). Immunoglobulins: history, present trends and safety aspects.In Waters, A. H. and Webster, A. D. B. (eds.) Intravenous Immunoglobulins in Immunodeficiency Syndromes and Idiopathic thrombocytopenic Purpura, pp. 3–9. ( London: Royal Society of Medicine. Congress series No. 84 )
2. Janeway, C. A. (1970). The development of clinical uses of immunoglobulins: a review. In Mester, E. (ed.) Immunoglobulins. Biological Aspects and Clinical Uses, pp. 3–14. ( Washington: National Academy of Sciences )
3. Barandun, S., Kistler, P., Jeunet, F. and Isiker, H. (1962). Intravenous administration of human gammaglobulin. Vox Sang, 7, 157 — 74
4. Hassig, A. (1986). Intravenous immunoglobulins: pharmacological aspects and therapeutic use. Vox Sang, 51. 10–17
5. Skvaril, F. (1986) Clinical relevance of IgG subclasses. In Morell, A. and Nydegger, U. E. (eds.) Clinical Use of Intravenous Immunoglobulins, pp. 37–45. ( London: Academic Press )